AION Labs, In Continued Partnership with BioMed X, Launches Fourth Global Call for Application: Prediction of Clinical Trial Outcome in Cancer Patient Populations
- Wednesday, June 29, 2022, 7:14
- Environment
- Add a comment
AION Labs, Israel-based alliance of AstraZeneca, Merck, Pfizer, Teva, Israel Biotech Fund and Amazon Web Services (AWS), seeks global research talent for new startup focused on: “Prediction of Clinical Trial Outcome in Biomarker-Stratified Cancer Patient Populations” REHOVOT, Israel and…
About the Author
adminasapcorp has written 38965 stories on this site.